-
2024-515884-69-00
5
2025-07-16
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
-
2024-513682-40-01
5
2025-07-04
Non-squamous (NSQ), Stage IV or Recurrent Non-small Cell Lung Cancer
-
2024-520381-62-00
6
2025-07-03
onychomycosis
-
2024-518812-38-00
4
2025-07-02
Non-small cell lung cancer (NSCLC)
-
2024-513869-39-00
5
2025-06-27
Obstructive Cardiomyopathy, Hypertrophic
-
2024-519219-32-00
5
2025-06-23
Heart Failure With Reduced Ejection Fraction
-
2023-507260-40-00
7
2025-06-16
Hemophilia B
-
2024-515764-31-00
10
2025-06-13
Non-small cell lung cancer
-
2024-515698-85-00
5
2025-06-12
Locally Advanced or Metastatic Non-small Cell Lung Cancer
-
2024-511534-12-00
7
2025-06-10
Advanced or Metastatic Solid Tumours
-
2024-517147-31-00
9
2025-05-23
Tumours, Gynecological
-
2024-517812-31-00
6
2025-05-21
Haemophilia A
-
2024-514953-31-00
4
2025-05-20
Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
-
2024-515984-68-00
4
2025-05-20
Non-small cell lung cancer (NSCLC)
-
2024-513375-40-00
4
2025-05-16
Melanoma
-
2024-517513-32-00
5
2025-05-16
Sjögren’s Syndrome
-
2023-506327-29-00
5
2025-05-14
Non-Small Cell Lung Cancer
-
2023-506460-14-00
5
2025-05-07
Chronic kidney disease (CKD) and hypertension.
-
2024-514465-18-00
9
2025-04-23
Advanced or Metastatic Non-Squamous NSCLC
-
2024-517284-23-00
5
2025-04-23
Active Psoriatic Arthritis
-
2024-514845-12-00
4
2025-03-28
Non-Cystic Fibrosis Bronchiectasis
-
2024-516219-25-00
5
2025-03-25
psoriatic arthritis
-
2024-515445-42-00
5
2025-03-24
Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast
-
2024-513547-82-00
5
2025-03-11
Transthyretin Amyloidosis